Meltem Ocak

2.1k total citations
54 papers, 1.5k citations indexed

About

Meltem Ocak is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Meltem Ocak has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Epidemiology. Recurrent topics in Meltem Ocak's work include Radiopharmaceutical Chemistry and Applications (24 papers), Neuroendocrine Tumor Research Advances (16 papers) and Medical Imaging Techniques and Applications (12 papers). Meltem Ocak is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Neuroendocrine Tumor Research Advances (16 papers) and Medical Imaging Techniques and Applications (12 papers). Meltem Ocak collaborates with scholars based in Türkiye, Austria and United States. Meltem Ocak's co-authors include Levent Kabasakal, Emre Demirci, Clemens Decristoforo, Türkay Toklu, Ahmet Araman, Metin Halaç, Bedii Kanmaz, Nami Yeyin, Onur Erdem Şahin and Mohammad Abuqbeitah and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Meltem Ocak

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meltem Ocak Türkiye 22 922 781 482 387 155 54 1.5k
Sabine Haufe Germany 17 671 0.7× 653 0.8× 445 0.9× 515 1.3× 331 2.1× 32 1.5k
Emre Demirci Türkiye 16 710 0.8× 827 1.1× 378 0.8× 225 0.6× 141 0.9× 53 1.2k
Federica Matteucci Italy 21 599 0.6× 664 0.9× 456 0.9× 312 0.8× 234 1.5× 86 1.3k
Paola Mapelli Italy 21 630 0.7× 593 0.8× 282 0.6× 194 0.5× 119 0.8× 89 1.2k
Sue Ping Thang Singapore 9 1.2k 1.3× 1.3k 1.7× 566 1.2× 219 0.6× 105 0.7× 28 1.7k
Arthur J. A. T. Braat Netherlands 23 752 0.8× 613 0.8× 500 1.0× 456 1.2× 301 1.9× 107 1.6k
Vincenzo Allegri Italy 15 417 0.5× 334 0.4× 392 0.8× 432 1.1× 324 2.1× 32 1.1k
Ismaheel O. Lawal South Africa 22 1.0k 1.1× 997 1.3× 515 1.1× 146 0.4× 51 0.3× 97 1.6k
Gian Carlo Montini Italy 13 414 0.4× 349 0.4× 356 0.7× 285 0.7× 213 1.4× 20 961
David A. Pattison Australia 21 453 0.5× 546 0.7× 396 0.8× 334 0.9× 226 1.5× 82 1.4k

Countries citing papers authored by Meltem Ocak

Since Specialization
Citations

This map shows the geographic impact of Meltem Ocak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meltem Ocak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meltem Ocak more than expected).

Fields of papers citing papers by Meltem Ocak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meltem Ocak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meltem Ocak. The network helps show where Meltem Ocak may publish in the future.

Co-authorship network of co-authors of Meltem Ocak

This figure shows the co-authorship network connecting the top 25 collaborators of Meltem Ocak. A scholar is included among the top collaborators of Meltem Ocak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meltem Ocak. Meltem Ocak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selçuk, Nalan Alan, Emre Demirci, Meltem Ocak, et al.. (2023). Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with [177Lu]Lu-PSMA–Refractory Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 64(10). 1574–1580. 16 indexed citations
2.
Ocak, Meltem, et al.. (2023). Leukocyte Labeling with Tc-99m-HMPAO: The Role of Leucocyte Numbers and Medication on the Labeling Efficacy and Image Quality. Molecular Imaging and Radionuclide Therapy. 32(1). 28–34. 1 indexed citations
3.
Ocak, Meltem, et al.. (2023). Targeted Alpha Radionuclide Therapy (TAT)-Ac-225 Radiopharmaceuticals. 9(1). 16–24.
4.
Ocak, Meltem & Levent Kabasakal. (2023). Targeted Alpha Therapy - Promising Radionuclides Beyond Ac-225. 9(2). 124–132.
5.
Ocak, Meltem, et al.. (2023). Application of response surface methodology and quality by design to [68Ga]Ga-PSMA-11 preparation. Journal of Radioanalytical and Nuclear Chemistry. 333(1). 43–51.
6.
Demirci, Emre, et al.. (2023). Initial Findings on the Use of [<sup>225</sup>Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors. Molecular Imaging and Radionuclide Therapy. 32(3). 226–232. 12 indexed citations
7.
Gillings, Nic, Martin Béhé, Clemens Decristoforo, et al.. (2022). EANM guideline on quality risk management for radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging. 49(10). 3353–3364. 19 indexed citations
8.
Selçuk, Nalan Alan, et al.. (2022). Almost Complete Response with a Single Administration <sup>225</sup>Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary. Molecular Imaging and Radionuclide Therapy. 31(2). 139–141. 6 indexed citations
9.
Gillings, Nic, Jim Ballinger, Martin Béhé, et al.. (2021). Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharmacy and Chemistry. 6(1). 8–8. 63 indexed citations
10.
Ocak, Meltem, Wissam Beaino, Alexander G. White, et al.. (2018). 64 Cu-Labeled Phosphonate Cross-Bridged Chelator Conjugates of c(RGDyK) for PET/CT Imaging of Osteolytic Bone Metastases. Cancer Biotherapy and Radiopharmaceuticals. 33(2). 74–83. 5 indexed citations
11.
Öbek, Can, Tünkut Doğanca, Emre Demirci, et al.. (2017). The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 44(11). 1806–1812. 84 indexed citations
12.
Demirci, Emre, et al.. (2016). Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging. Nuclear Medicine Communications. 37(11). 1169–1179. 115 indexed citations
13.
Sönmezoğlu, Kerim, Tuğrul Elverdi, Metin Halaç, et al.. (2016). The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma. Nuclear Medicine Communications. 38(1). 76–83. 15 indexed citations
14.
Kabasakal, Levent, et al.. (2015). Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging. Nuclear Medicine Communications. 36(6). 582–587. 118 indexed citations
15.
Demirci, Emre, Meltem Ocak, Levent Kabasakal, et al.. (2014). 68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 41(7). 1461–1462. 119 indexed citations
16.
Ocak, Meltem, et al.. (2013). The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours. Molecular Imaging and Radionuclide Therapy. 22(3). 76–84. 12 indexed citations
17.
Demirci, Emre, Meltem Ocak, Levent Kabasakal, et al.. (2013). Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours. Nuclear Medicine Communications. 34(8). 727–732. 11 indexed citations
18.
Ocak, Meltem, et al.. (2012). The different distribution patterns of FDG and FDG-labelled WBC in inflammatory and infectious lesions. European Journal of Nuclear Medicine and Molecular Imaging. 39(10). 1660–1661. 4 indexed citations
19.
Kabasakal, Levent, Emre Demirci, Meltem Ocak, et al.. (2012). Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 39(8). 1271–1277. 94 indexed citations
20.
Ocak, Meltem, et al.. (2011). Intraoperative Localization of Recurrent Medullary Carcinoma of the Thyroid Using Tc-99m HYNIC-TATE and a Surgical Gamma Probe. Clinical Nuclear Medicine. 36(9). 831–833. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Haufe Breakdown of academic impact, for papers by Emre Demirci Breakdown of academic impact, for papers by Federica Matteucci Breakdown of academic impact, for papers by Paola Mapelli Breakdown of academic impact, for papers by Sue Ping Thang Breakdown of academic impact, for papers by Arthur J. A. T. Braat Breakdown of academic impact, for papers by Vincenzo Allegri Breakdown of academic impact, for papers by Ismaheel O. Lawal Breakdown of academic impact, for papers by Gian Carlo Montini Breakdown of academic impact, for papers by David A. Pattison
Rankless by CCL
2026